System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Golo Ahlenstiel is an expert in Gastroenterology at Blacktown Mount Druitt Hospital (Australia). As of October 2026, ScienceLeadR ranks Golo Ahlenstiel in the top 1% of experts worldwide for Hepatitis. Golo Ahlenstiel has authored 181 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 783 (community average: 125). How the SLR is computed.

LeadR Profile

Golo Ahlenstiel Blacktown Mount Druitt Hospital Australia
783 ScienceLeadR Reputation 783

Unlock

Register Login
Network Map

Gastroenterology

Subspecialties: Hepatology - Immunology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Golo Ahlenstiel is Chair of Medicine at Western Sydney University and Clinical Network Director for Subspecialty Medicine at Western Sydney Local Health District. He is an established academic hepatologists with strong research interests in liver immunology, metabolic liver disease and cancer immunotherapy.

Dr Ahlenstiel is faculty member at the Westmead Institute for Medical Research and Lead of the Liver Immunology Group at Storr Liver Centre.

Organizations

Career arc: 2003 - 2026
Source: PubMed

Westmead Institute for Medical Research

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 181

Citations

Citations: 6 760 1st author: 16 Last author: 60 Unique author: 2

Main journals

J Hepatol 13
Gastrointest Endosc 9
Gastroenterology 7
Ann Oncol 6
Endoscopy 4

Best Journals

Ann Oncol 5
J Clin Oncol 2
Gut 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Non-risk-based HCV screening at point of care: a prospective pilot.
PMID 42337461 — research design, pilots, point-of-care systems, viruses, outpatients, physical exertion, education, communicable diseases		BMC Infect Dis20260
Remission of type 2 diabetes following a metabolic program including surgery: a comparative study of young-onset and older-onset type 2 diabetes.
PMID 42202887 — diabetes mellitus, obesity, therapeutics, diabetes mellitus, type 2		Diabetes Res Clin Pract20260
Comparison of immunity-boosting regimens for COVID-19 upon initiation of immunosuppressive therapy (CIRCUIT): study protocol for a randomised, controlled clinical trial.
PMID 42031476 — vaccines, vaccination, covid-19, immunity, transplants, research, therapeutics, immunosuppression therapy		BMJ Open20260
C3d Complement Activation and Antibody Immunity in Convalescent COVID-19: Insights From Adults and Children.
PMID 41968603 — cells, antibody formation, complement c3d, sars-cov-2, covid-19, immunity, complement system proteins, complement activation, infections, child		J Immunol Res20260
Prognostic Role of Acute-on-Chronic Liver Failure in Acute Variceal Bleeding: A Multicenter Retrospective Study in Australia.
PMID 41944030 — mortality, acute-on-chronic liver failure, hemorrhage, retrospective studies, liver, liver failure		Gut Liver20261

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 5
Phase 1/Phase 2 1
Phase 2 1
Phase 3 1
Phase 4 1

By status:

Recruiting 5
Completed 3
Terminated 1

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 3
multicentric5to9 2
multicentricup10 1

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Immunosuppression and COVID 19 Boosters
NCT05415267 — diphtheria, vaccines, covid-19 vaccines, rna, messenger, vaccination, covid-19, immunity, tetanus toxoid, therapeutics, immunosuppression therapy, toxoids, tetanus, immunology		Phase 3Recruiting2023
Real World Assessment of People Living With Chronic Hepatitis B in Australia
NCT04914611 — hepatitis, chronic, hepatitis b, hepatitis b, chronic, hepatitis		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS